Hims & Hers Health, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Investigation

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. regarding possible violations of federal securities laws, particularly related to alleged misrepresentations and omissions by the company and its executives [1][2] Group 1: Legal and Regulatory Issues - Novo Nordisk terminated its collaboration with Hims & Hers Health due to serious concerns over the company's sale of compounded medications marketed as personalized treatments, alleging that Hims may have violated regulations by mass-distributing semaglutide-based drugs that could contain unauthorized foreign substances [3] Group 2: Investor Information - Investors who purchased Hims & Hers securities and incurred significant losses may be eligible to participate in a potential class action to recover their losses [2]